As a dedicated shareholder holding over 0.5% ownership in X4 Pharmaceuticals, I feel a pressing obligation to ensure that the company's direction aligns with both shareholder interests and long-term viability. Like many investors, I have invested not only my resources but also my trust in the company's leadership and vision. However, recent developments have raised concerns about transparency, decision-making, and overall strategic progress.

Despite the promise of X4’s pipeline, the company’s stock performance has been extremely poor and unacceptable. Over the past year, shares of X4 Pharmaceuticals (NASDAQ: XFOR) have declined by more than 90%, falling from over $1.70 in early 2024 to below $0.15 (pre-split). Even more concerning, over the past five years the stock has lost approximately 99% of its value, devastating long-term investors and reflecting a prolonged lack of value creation.

I am calling for a strategic review at X4 Pharmaceuticals—a necessary step to evaluate and enhance our operational efficiency, market competitiveness, and shareholder value. Regular strategic assessments are vital for any corporation aiming to adapt to rapidly changing industry landscapes and to maintain stakeholder trust.

There are countless examples in the industry where timely strategic reviews have led to stronger positioning and increased investor confidence. By undertaking a comprehensive strategic review, X4 Pharmaceuticals can identify potential strengths, areas of improvement, and opportunities for innovation. This process would involve assessing current strategies, operations, management practices, and market positioning, identifying gaps, and devising actionable plans to address them.

The initiation of this review should be conducted transparently, involving independent experts and gaining insights from various stakeholders, particularly shareholders. This collaborative approach will ensure an unbiased evaluation and foster an environment conducive to sustainable growth and success.

This petition seeks the support of other concerned shareholders to join voices and advocate for a strategic review. Our influence as collective shareholders can initiate positive changes that align with our shared goals of value enhancement and sustainable success.

Sign this petition if you believe in responsible and proactive governance at X4 Pharmaceuticals that prioritizes strategic reviews to secure a successful future for all shareholders. Let’s work together to make our voices heard and drive the change we envision for our company.

Important - Please include the number of shares in comments.  Feel free to contact me directly with any questions at sskinner5@yahoo.com